INCENTIVE STOCK OPTION GRANT AGREEMENTIncentive Stock Option Grant Agreement • July 2nd, 2014 • Corbus Pharmaceuticals Holdings, Inc. • Pharmaceutical preparations • Delaware
This Stock Option Grant Agreement (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between Corbus Pharmaceuticals Holdings, Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Optionee”).
Registration Rights AgreementRegistration Rights Agreement • July 2nd, 2014 • Corbus Pharmaceuticals Holdings, Inc. • Pharmaceutical preparations • New York
This Registration Rights Agreement (this “Agreement”) is made and entered into effective as of April 11, 2014 (the “Effective Date”) between Corbus Pharmaceuticals Holdings, Inc., a Delaware corporation (the “Company”), and the persons who have executed the signature page(s) hereto (each, a “Purchaser” and collectively, the “Purchasers”).
SUBSCRIPTION AGREEMENTSubscription Agreement • July 2nd, 2014 • Corbus Pharmaceuticals Holdings, Inc. • Pharmaceutical preparations • New York
EMPLOYMENT AGREEMENTEmployment Agreement • July 2nd, 2014 • Corbus Pharmaceuticals Holdings, Inc. • Pharmaceutical preparations • Massachusetts
This Employment Agreement, effective as of April 11, 2014 (the “Effective Date”), is between Corbus Pharmaceuticals Holdings, Inc. (the “Company”) and Yuval Cohen (the “Executive”).
NONQUALIFIED STOCK OPTION GRANT AGREEMENTNonqualified Stock Option Grant Agreement • July 2nd, 2014 • Corbus Pharmaceuticals Holdings, Inc. • Pharmaceutical preparations • Delaware
This Stock Option Grant Agreement (the “Grant Agreement”) is made and entered into effective on the Date of Grant set forth in Exhibit A (the “Date of Grant”) by and between Corbus Pharmaceuticals Holdings, Inc., a Delaware corporation (the “Company”), and the individual named in Exhibit A hereto (the “Optionee”).
PLACEMENT AGENCY AGREEMENTPlacement Agency Agreement • July 2nd, 2014 • Corbus Pharmaceuticals Holdings, Inc. • Pharmaceutical preparations • New York
This Placement Agency Agreement ("Agreement") sets forth the terms upon which Aegis Capital Corp., a New York corporation, and a registered broker-dealer and member of the Financial Industry Regulatory Authority ("FINRA") (the “Placement Agent”), shall be engaged by JB Therapeutics, Inc., a Delaware corporation (“JBT”) and Corbus Pharmaceuticals Holdings, Inc., a Delaware corporation (“Issuer”), to act as exclusive Placement Agent in connection with the private placement (the “Offering”) of units (“Units”) of securities of Issuer, with each Unit consisting of (i) 250,000 shares of common stock, par value $0.0001 per share (the “Common Stock”), of Issuer (the “Shares”) and (ii) 250,000 warrants (the “Warrants”), with each Warrant entitling the holder to purchase one share of Common Stock for a five-year period at an exercise price of $1.00 per share. The Offering will consist of a minimum of 18 Units ($4,500,000) (the “Minimum Amount”) and a maximum of 36 Units ($9,000,000) (the “Maximu
AGREEMENT BETWEEN ORCHESTRA MEDICAL VENTURE, LLC AND CORBUS PHARMACEUTICALS HOLDINGS, INC.Agreement Between Orchestra • July 2nd, 2014 • Corbus Pharmaceuticals Holdings, Inc. • Pharmaceutical preparations • New York
THIS AGREEMENT is made as of this 21st day of March 2014, by and among Orchestra Medical Ventures, LLC., a Delaware limited liability company (“Orchestra”) and Corbus Pharmaceuticals Holdings, Inc., a Delaware corporation (“Corbus”).
Restricted Stock AgreementRestricted Stock Agreement • July 2nd, 2014 • Corbus Pharmaceuticals Holdings, Inc. • Pharmaceutical preparations • Delaware
THIS RESTRICTED STOCK AGREEMENT (the “Agreement”) is made as of the __ day of __________________, ____ (the “Effective Date”), by and between Corbus Pharmaceuticals Holdings, Inc., a Delaware corporation (the “Company”) and [•] (the “Participant”).
VOTING AGREEMENTVoting Agreement • July 2nd, 2014 • Corbus Pharmaceuticals Holdings, Inc. • Pharmaceutical preparations • New York
This VOTING AGREEMENT (this “Agreement”) is entered into as of April 11, 2014 (the “Effective Date”) by and among Corbus Pharmaceuticals Holdings, Inc., a Delaware corporation (the “Company”), the parties listed as stockholders of JB Therapeutics, Inc. (the “JB Therapeutics Stockholders”) on the signature pages hereto and the parties listed as stockholders of the Company (the “Holdings Stockholders”) on the signature pages hereto (each, a “Stockholder” and collectively, the “Stockholders”).
